Q4 2020 Holdings
Filed 2021-02-11 | 35 holdings | $326.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $296.6M | 10,542,790 | 90.8% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $18.9M | 943,666 | 5.8% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $10.2M | 568,500 | 3.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $193.6K | 5,827,415 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $128.1K | 5,009,219 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $79.2K | 1,917,157 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $62.3K | 3,566,912 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $61.4K | 2,309,554 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $60.9K | 1,312,999 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $53.7K | 895,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $44.9K | 3,053,107 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $40.2K | 2,182,789 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $32.4K | 2,571,450 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $31.2K | 1,405,045 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $21.7K | 1,001,421 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.3K | 899,700 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $17.2K | 2,494,500 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $15.6K | 1,501,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $15.6K | 1,437,028 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $15.5K | 341,954 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $11.0K | 3,190,079 | 0.0% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $10.0K | 550,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.2K | 168,000 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $8.1K | 2,061,758 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $7.9K | 731,436 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $7.9K | 841,908 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.4K | 153,500 | 0.0% |
| Allena Pharmaceuticals Inc(ALNAEUR) | COM | 018119107 | $4.3K | 3,330,373 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $3.9K | 1,296,743 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.3K | 202,803 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $2.5K | 241,000 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $1.7K | 35,750 | 0.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $1.5K | 1,538,316 | 0.0% |
| Nabriva Therapeutics PLC | SHS NEW | G63637113 | $1.0K | 425,650 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $144 | 61,541 | 0.0% |